Synchromate 0.25mg/ml, Solution for Injection for Cattle and Horses
Active ingredient: Cloprostenol
Form
Injection
Species
Manufacturer
Alivira Animal Health Limited
VMD MA No.
61503/5000
The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Cloprostenol
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Synchromate 0.25mg/ml, Solution for Injection for Cattle and Horses — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.
-
-
Sub-oestrus (or non detected oestrus)
After diagnosing the presence of a corpus luteum - by rectal palpation - treat with the
product and inseminate those animals showing heat. Those animals which do not show
heat to be re-examined 11 days later and may receive a second injection and be bred at
oestrus or at fixed times; once at 72-84 hours or twice at 72 and 96 hours.
Induction of parturition
Induces parturition in the period around normal term. Induction should take place as close
to the predicted calving date as possible and not more than 10 days before. Induction
should not be attempted before day 270 of gestation measured from the confirmed day
of conception, except in pathological conditions. All treated animals must receive
adequate supervision. In common with other methods of shortening the gestation period
a higher than usual incidence of retention of the foetal membranes is to be expected.
Termination of normal pregnancy
Normal pregnancy can be terminated in cattle from one week after conception until the
150th day of gestation. Best results are obtained during the first 100 days. Treated
animals should be kept under observation until expulsion of the foetus and placenta is
complete.
Termination of abnormal pregnancy
- Mummified foetus - induction of luteolysis at any stage of pregnancy will result in the
expulsion of the mummified foetus from the uterus into the vagina from which manual
removal may be necessary. Normal cyclical activity should then follow.
- Hydrops of the foetal membrane - Pathological accumulation of placental fluids can
cause severe physiological complications and death. Surgical drainage is not usually
successful in alleviating the condition. In such cases, a single dose may be used to induce
parturition.
Chronic endometritis (Pyometra)
Treat with a single dose. In long-standing cases treatment may be repeated after 10-14
days.
Ovarian luteal cysts
Where cystic ovaries associated with persistent luteal tissue and absence of heat are
diagnosed, the product has proved to be effective in correcting the condition and bringing
about a return to cyclicity.
Other indications: Controlled breeding
Examples of programmes which have been used are:
i) A single treatment of cattle with palpable evidence of a corpus luteum, followed by
breeding on detection of the subsequent oestrus.
ii) Detection of oestrus for 6 days, breeding those animals seen in heat; a single treatment
is given to all non-served animals on the 6th day and these cattle are bred at subsequent
oestrus.
iii) Two injections 11 days apart, breeding at oestrus or at fixed times (see below).
iv) As iii) above, but breeding any animals showing oestrus before the second injection.
Thus the second dose is given only to those cattle not seen in oestrus during that time
and is followed by breeding either on signs of oestrus or at fixed times (see below).
Cattle which respond to a single prostaglandin injection will normally do so within 6 days
of treatment. The response time after two injections is more rapid. Animals may be
inseminated on detection of oestrus in any of the breeding programmes. However, fixed
time insemination should only be used following the second of a two injection programme
(i.e. examples iii) and iv)). In the latter case insemination should be performed either once
at 72-84 hours or twice at 72 and 96 hours after the second injection, as preferred.
Double ‘fixed-time’ insemination may give superior results to a single insemination.
However, economic factors in the particular herd may outweigh such a benefit.
For successful treatment, animals should be cycling normally. Rectal examination before
treatment should avoid the disappointment of treating noncycling (an-oestrus) or pregnant
animals.
Attention should be directed to the diet and condition of the treated animals. Sudden
changes in feeding levels, in feed constituents and in housing, etc should be avoided
around the time of the breeding programme, as should any other factor, such as
regrouping, which could reasonably be expected to lead to stress.
If artificial insemination is to be used, the quality of semen and insemination technique
should be assured beforehand.
A recommended guideline for use of the product in dairy cows would be as follows:
After the first injection, inseminate any cows showing signs of heat.
Animals that do not show signs of heat should be injected 11 days after the first injection
and then inseminated 72-96 hours later.
Horses
(Ponies and donkeys: single dose of 0.5-1.0 ml (equivalent to 125-250 mcg of
cloprostenol) by intramuscular injection. Thoroughbreds, hunters and heavy horses: 1-2
ml (equivalent to 250- 500 mcg cloprostenol) by intramuscular injection).
- Induction of luteolysis following early foetal death and resorption: about 8-10% of all
mares which conceive lose the conceptus during the first 100 days of pregnancy.
Persistence of luteal function in the ovary precludes an early return to oestrus.
- Termination of persistent dioestrus: non-pregnant mares frequently and spontaneously
go to and out of periods of prolonged dioestrus. A very high proportion of mares in this
category i.e. not cycling, are in prolonged dioestrus rather than anoestrus, particularly in
the latter part of the breeding season.
- Termination of pseudopregnancy: some mares which are covered at normal oestrus and
subsequently found to be empty (but not having lost or resorbed a conceptus) display
clinical signs of pregnancy. These animals are said to be “pseudopregnant”.
- Treatment of lactation anoestrus: failure of lactating mares to cycle again for several
months after exhibiting an early ‘foal heat’ can be avoided.
- Establishing oestrous cycles in barren/maiden mares: some of these animals will be
found, on examination, to have a functional corpus luteum and are suffering from
abnormal persistence of luteal function or are simply failing to exhibit normal oestrous
behaviour (“silent heat”) while ovarian cyclicity continues.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Do not administer the product to pregnant cows unless you wish to induce parturition or
therapeutic abortion, as luteolysis may result in loss of the foetus.
(>1 animal / 10 animals treated):
- Common
(1 to 10 animals / 100 animals treated):
- Uncommon
(1 to 10 animals / 1,000 animals treated):
-Rare
(1 to 10 animals / 10,000 animals treated):
severe life-threatening local bacterial
infections may occur associated with
clostridial proliferation at the injection site
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
anaphylactic-type reactions require
immediate medical care
It is important to keep treated animals under observation and, if such infection occurs
aggressive antibiotic therapy, particularly covering clostridial species, should be
employed as a matter of urgency. Careful aseptic techniques should be employed to
decrease the possibility of these infections.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See also the last section 16 of the package leaflet for
respective contact details.
Due to the possibility of post-injection bacterial infections, careful aseptic techniques
should be employed.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Prostaglandins of the type may be absorbed through the skin and may cause
bronchospasm or miscarriage.
Care should be taken when handling the product to
CONTACT.
Pregnant women, women of childbearing age, asthmatics and persons with bronchial or
other respiratory tract diseases should exercise caution when handling the product.
Wear disposable impervious gloves when administering the product.
People with a known hypersensitivity to cloprostenol or chlorocresol should avoid contact
with the product.
Direct contact with the skin or eyes may cause irritation.
Accidental spillage on the skin should be washed immediately with soap and water.
If accidental contact with eyes occurs, rinse the affected eyes thoroughly with clean, fresh
water.
The possible incidence of bronchospasm with the product is unknown.
In case of accidental self-injection or spillage onto the skin seek medical advice
immediately, particularly as shortness of breath may occur, and show the package leaflet
or label to the physician.
Do not eat, drink or smoke while handling the product.
Wash hands after use
Special precautions for the protection of the environment:
Not applicable
conditions.
Keep vial in the outer carton in order to protect from light.
Meat and offal: 1 day
Milk: zero hours
Horses
Not authorised for use in horses intended for human consumption.
4.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Other Products Containing Cloprostenol
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Bioestrovet 0.250 mg/ml Solution for Injection for Cattle
POM-VVetoquinol UK Limited
Bioestrovet 0.250 mg/ml Solution for Injection for Cattle
POM-VVetoquinol SA
Bioestrovet Swine 0.0875 mg/ml Solution for Injection for Pigs
POM-VVetoquinol UK Limited
Cevaprost 250 µg/ml Solution for Injection
POM-VCeva Sante Animale
Cevaprost 250 µg/ml Solution for Injection
POM-VCeva Sante Animale
Cyclix 250 microgram/ml Solution for Injection for Cattle
POM-VVirbac
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
KatKin Fresh Cat Food
The UK's top-rated cat food. 100% fresh, human-quality meat, gently cooked and delivered frozen. Vet-formulated for every life stage.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Alizin 30 mg/ml Solution for Injection for Dogs
POM-VAglepristone
Alizin 30 mg/ml Solution for Injection for Dogs
POM-VAglepristone
Animalintex Hoof Treatment Poultice
AVM-GSLBoric Acid
Animalintex Poultice
AVM-GSLBassorin E Powder + Boric Acid
Bexatil 15 mg Tablets for Cats
POM-VBexagliflozin
Bexatil 15 mg Tablets for Cats
POM-VBexagliflozin
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.